Results
1374
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1374 companies
Bioventix
Market Cap: UK£129.3m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£24.75
7D
1.6%
1Y
-34.9%
Bliss GVS Pharma
Market Cap: ₹15.3b
Engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally.
506197
₹145.10
7D
-3.6%
1Y
8.2%
Wuhan YZY Biopharma
Market Cap: HK$1.3b
A biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases.
2496
HK$6.80
7D
11.8%
1Y
14.9%
Coherus Oncology
Market Cap: US$168.5m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.50
7D
-6.8%
1Y
42.9%
AFT Pharmaceuticals
Market Cap: NZ$291.5m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.78
7D
6.1%
1Y
-12.0%
BIOBIJOULtd
Market Cap: ₩236.0b
Engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea.
A489460
₩15,690.00
7D
-4.0%
1Y
n/a
Enanta Pharmaceuticals
Market Cap: US$165.7m
A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.
ENTA
US$7.90
7D
3.4%
1Y
-21.4%
Protara Therapeutics
Market Cap: US$165.5m
A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
TARA
US$4.25
7D
33.2%
1Y
124.9%
Kwang Dong Pharmaceutical
Market Cap: ₩231.0b
Operates as a human healthcare provider in South Korea.
A009290
₩5,880.00
7D
-0.5%
1Y
-0.5%
MaxCyte
Market Cap: US$163.1m
A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
MXCT
US$1.53
7D
0.7%
1Y
-60.5%
AVITA Medical
Market Cap: US$162.5m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$5.20
7D
-4.9%
1Y
-51.6%
Jagsonpal Pharmaceuticals
Market Cap: ₹14.3b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹214.95
7D
-11.6%
1Y
29.6%
Eledon Pharmaceuticals
Market Cap: US$161.1m
Operates as a clinical stage biotechnology company.
ELDN
US$2.69
7D
5.5%
1Y
8.0%
Scilex Holding
Market Cap: US$160.6m
Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
SCLX
US$29.21
7D
0.4%
1Y
-11.3%
Cenra
Market Cap: NT$4.9b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$33.50
7D
0.1%
1Y
-16.0%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 22.65
7D
-1.5%
1Y
-19.5%
JW Holdings
Market Cap: ₩224.5b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,245.00
7D
-3.1%
1Y
3.5%
OSE Immunotherapeutics
Market Cap: €135.1m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€5.88
7D
3.9%
1Y
-27.9%
Genelux
Market Cap: US$157.2m
A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.
GNLX
US$4.20
7D
1.0%
1Y
93.5%
Aroa Biosurgery
Market Cap: AU$239.8m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.69
7D
3.7%
1Y
26.4%
Adocia
Market Cap: €133.1m
A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.
ADOC
€7.30
7D
-3.9%
1Y
26.7%
BICO Group
Market Cap: SEK 1.5b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 20.66
7D
-1.9%
1Y
-53.2%
StemCyte International
Market Cap: NT$4.7b
Operates cord blood cell banks in the United States and Taiwan.
4178
NT$24.60
7D
0.4%
1Y
n/a
Sunho Biologics
Market Cap: HK$1.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems.
2898
HK$7.96
7D
3.4%
1Y
53.7%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.14
7D
-1.4%
1Y
62.1%
Photocure
Market Cap: NOK 1.5b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 57.60
7D
-2.9%
1Y
9.7%
Actuate Therapeutics
Market Cap: US$152.4m
A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
ACTU
US$6.89
7D
3.8%
1Y
9.9%
Avalo Therapeutics
Market Cap: US$151.9m
A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.
AVTX
US$10.80
7D
-8.7%
1Y
14.9%
Achieve Life Sciences
Market Cap: US$151.8m
A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
ACHV
US$3.01
7D
6.7%
1Y
-36.9%
Cassava Sciences
Market Cap: US$149.8m
A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
SAVA
US$2.99
7D
31.1%
1Y
-89.5%
Amicogen
Market Cap: ₩211.0b
Operates as an industrial biotechnology company in South Korea and internationally.
A092040
₩3,850.00
7D
-3.8%
1Y
-16.8%
Corbus Pharmaceuticals Holdings
Market Cap: US$148.8m
A biopharmaceutical company, develops products to defeat serious illness.
CRBP
US$12.11
7D
5.3%
1Y
-42.1%
Formosa Pharmaceuticals
Market Cap: NT$4.5b
A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.
6838
NT$30.05
7D
-2.0%
1Y
-31.5%
Kotra Industries Berhad
Market Cap: RM 627.4m
An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.
KOTRA
RM 4.23
7D
-0.7%
1Y
-4.1%
Cybin
Market Cap: US$147.7m
A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.
CYBN
US$5.86
7D
-2.3%
1Y
-39.0%
SunWay Biotech
Market Cap: NT$4.5b
Focuses on professional research and development, and technical material manufacturing and processing business.
1271
NT$74.50
7D
0.7%
1Y
-11.9%